Click image to view it in full size

Cancer with higher rates of recurrence are difficult to treat. Cancer remission can happen at the original site (ie, a locoregional recurrence) or in a different location (ie, as a metastatic disease). The timing as well as pattern of cancer mainly depends on cancer type and diagnosis stage. Therefore, cancer survivors are at a higher risk of developing a second primary cancer and these can occur due to several clinical factors such as initial treatment of primary cancer (for example, chemotherapy and radiation therapy), lifestyle habits (such as smoking, obesity) and genetic factors. Such recurrences can be prevented through regular consultations with primary care physicians, lifestyle interventions, cancer as well as genetic counseling.

Improvements in cancer treatments and availability of supportive care has increased the cancer survival rates significantly. There are about 15 million cancer survivors globally and it is estimated to reach 20 million by 2025. However, there are huge disparities amongst cancer survivors mainly associated with cancer-related health problems with pre-existing conditions and problems related to aging. Therefore, strategies and initiatives to improve quality of care has become a priority amongst survivorship advocates and policy makers. In addition, cancer recurrence are one of the major concerns for patients as well as caregivers, with the recurrence rates varying between different types of cancer. These rates are also dependent on cancer stage, histology, genetic factors, patient-related factors, and treatments.

The purpose of this research service is to present a comprehensive analysis of NA and Europe along with regions such as APAC, that provides opportunity for market penetration and growth as well as highlight the growth opportunities in Cancer Survivorship Care which can be leveraged by existing and future participants. It will highlight the market dynamics and its key players. Due to availability of favorable reimbursement policies in the US, survivorship programs have high footprint in cancer institutes located in the region. Meanwhile, fragmented nature of healthcare and absence of reimbursements in Europe and APAC, cancer survivorship programs have limited popularity. Companies have high focus on providing case management services to survivors. Major health IT and medtech companies offering integration between electronic health records (EHR) platforms or cancer treatment platforms with cancer institutes to extend care beyond intervention and treatment. Non-Profit Organizations mainly offer help to cancer survivors in counseling, organizing patient support groups and wellness. These are free and professional support that are necessary to manage with any post-cancer treatment and help a cancer survivor to easily transition to normal life.